Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

Cancer Cell

Volumn 1, Issue 2, 2002, Pages 133-143

  Yeoh, Eng Juh ^a,b   Ross, Mary E ^a   Shurtleff, Sheila A ^a   Williams, W Kent ^a   Patel, Divyen ^a   Mahfouz, Rami ^a   Behm, Fred G ^a   Raimondi, Susana C ^a   Relling, Mary V ^a   Patel, Anami ^a   Cheng, Cheng ^a   Campana, Dario ^a   Wilkins, Dawn ^c   Zhou, Xiaodong ^c   Li, Jinyan ^d   Liu, Huiqing ^d   Pui, Ching Hon ^a   Evans, William E ^a   Naeve, Clayton ^a   Wong, Limsoon ^d   Downing, James R ^a   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d Lab for Information Technology   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; DISEASE CLASSIFICATION; DNA MICROARRAY; GENE EXPRESSION; HUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; TREATMENT OUTCOME; UNINDEXED SEQUENCE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALGORITHM; BIOLOGY; CHILD; CLASSIFICATION; GENE EXPRESSION PROFILING; GENETICS; IMMUNOPHENOTYPING; METHODOLOGY; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; TREATMENT FAILURE;

ALGORITHMS; CHILD; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECURRENCE; RISK FACTORS; TREATMENT FAILURE;

EID: 19044399684     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00032-6     Document Type: Article

References (25)

1. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511.
2. Arico, M., Valsecchi, M.G., Camitta, B., Schrappe, M., Chessells, J.M., Baruchel, A., Gaynon, P.S., Silverman, L., Janka-Schaub, G., Kamps, W., et al. (2000). Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N. Engl. J. Med. 342, 998-1006.
3. Armstrong, S.A., Staunton, J.E., Silverman, L.B., Pieters, R., den Boer, M.L., Minden, M.D., Sallan, S.E., Lander, E.S., Golub, T.R., and Korsmeyer, S.J. (2002). MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 30, 41-47.
4. Biondi, A., Cimino, G., Pieters, R., and Pui, C.H. (2000). Biological and therapeutic aspects of infant leukemia. Blood 96, 24-33.
5. Downing, J.R. (1999). The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance. Br. J. Haematol. 106, 296-308.
6. Ferrando, A.A., Neuberg, D.S., Staunton, J., Loh, M.L., Haurd, C., Raimondi, S.C., Behm, F.G., Pui, C.-H., Downing, J.R., Gilliland, D.G., et al. (2002). Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75-87.
7. Gamou, T., Kitamura, E., Hosoda, F., Shimizu, K., Shinohara, K., Hayashi, Y., Nagase, T., Yokoyama, Y., and Ohki, M. (1998). The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8 (ETO) family. Blood 91, 4028-4037.
8. Georgescu, M.M., Kirsch, K.H., Shishido, T., Zong, C., and Hanafusa, H. (1999). Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-κB. Mol. Cell. Biol. 19, 1171-1181.
9. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.P., Coller, H., Loh, M.L., Downing, J.R., Caligiuri, M.A., et al. (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537.
10. Graham, D.K., Dawson, T.L., Mullaney, D.L., Snodgrass, H.R., and Earp, H.S. (1994). Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ. 5, 647-657.
11. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
12. Heerema, N.A., Sather, H.N., Ge, J., Arthur, D.C., Hilden, J.M., Trigg, M.E., and Reaman, G.H. (1999). Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group. Leukemia 13, 679-686.
13. Hogenesch, J.B., Ching, K.A., Batalov, S., Su, A.I., Walker, J.R., Zhou, Y., Kay, S.A., Schultz, P.G., and Cooke, M.P. (2001). A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes. Cell 106, 413-415.
14. Hunger, S.P. (1996). Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 87, 1211-1224.
15. Perou, C.M., Jeffrey, S.S., van de Rijn, M., Rees, C.A., Eisen, M.B., Ross, D.T., Pergamenschikov, A., Williams, C.F., Zhu, S.X., Lee, J.C., et al. (1999). Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA 96, 9212-9217.
16. Petit, M.M., Schoenmakers, E.F., Huysmans, C., Geurts, J.M., Mandahl, N., and Van de Ven, W.J. (1999). LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes. Genomics 57, 438-441.
17. Pui, C.H., and Evans, W.E. (1998). Acute lymphoblastic leukemia. N. Engl. J. Med. 339, 605-615.
18. Pui, C.H., Frankel, L.S., Carroll, A.J., Raimondi, S.C., Shuster, J.J., Head, D.R., Crist, W.M., Land, V.J., Pullen, D.J., and Steuber, C.P. (1991). Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. Blood 77, 440-447.
19. Pui, C.H., Boyett, J.M., Rivera, G.K., Hancock, M.L., Sandlund, J.T., Ribeiro, R.C., Rubnitz, J.E., Behm, F.G., Raimondi, S.C., Gajjar, A., et al. (2000). Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia 14, 2286-2294.
20. Pui, C.H., Campana, D., and Evans, W.E. (2001). Childhood acute lymphoblastic leukaemia - current status and future perspectives. Lancet Oncol. 2, 597-607.
21. Raimondi, S.C., Behm, F.G., Roberson, P.K., Williams, D.L., Pui, C.H., Crist, W.M., Look, A.T., and Rivera, G.K. (1990). Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J. Clin. Oncol. 8, 1380-1388.
22. Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J.P., et al. (2001). Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. USA 98, 15149-15154.
23. Schrappe, M., Reiter, A., Ludwig, W.D., Harbott, J., Zimmermann, M., Hiddemann, W., Niemeyer, C., Henze, G., Feldges, A., Zintl, F., et al. (2000). Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood 95, 3310-3322.
24. Silverman, L.B., Gelber, R.D., Dalton, V.K., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., et al. (2001). Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 97, 1211-1218.
25. Su, A.I., Welsh, J.B., Sapinoso, L.M., Kern, S.G., Dimitrov, P., Lapp, H., Schultz, P.G., Powell, S.M., Moskaluk, C.A., Frierson, H.F., Jr., and Hampton, G.M. (2001). Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res. 61, 7388-7393.